No VTE Prophylaxis Medication Administered Or Ordered Union
eCQM Union
Performance/Reporting Period
2021
Data Elements contained within the Union
["Medication, Administered": "Injectable Factor Xa Inhibitor for VTE Prophylaxis"]
Value Set Description from VSAC
Clinical Focus: This value set contains concepts that represent codes which identify injectable factor Xa inhibitors, which are used for venous thromboembolism (VTE) prophylaxis.
Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Medication. The intent of this data element is to identify patients who are on a select injectable factor Xa inhibitor as prophylaxis for VTE.
Inclusion Criteria: Includes only relevant concepts associated with injectable factor Xa inhibitor medications. These are RxNorm codes.
Exclusion Criteria: No exclusions.
Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Medication. The intent of this data element is to identify patients who are on a select injectable factor Xa inhibitor as prophylaxis for VTE.
Inclusion Criteria: Includes only relevant concepts associated with injectable factor Xa inhibitor medications. These are RxNorm codes.
Exclusion Criteria: No exclusions.
Constrained to codes in the Medication, Administered: Injectable Factor Xa Inhibitor for VTE Prophylaxis value set (2.16.840.1.113883.3.117.1.7.1.211)
QDM Datatype and Definition
"Medication, Administered"
Data elements that meet criteria using this datatype should document that the medication indicated by the QDM category and its corresponding value set was actually administered to the patient.
Timing:
- relevant dateTime references the time the medication is administered if it was given or taken at a single point in time.
- relevantPeriod references a start and stop time for medication administration if the administration event occurred over a time interval (e.g., an intravenous infusion). The relevantPeriod addresses:
- startTime - when a single medication administration event starts (e.g., the initiation of an intravenous infusion).
- stopTime - when a single medication administration event ends (e.g., the end time of the intravenous infusion).
- author dateTime references the time the action was recorded.
- Refer to the eCQM expression to determine allowable timings to meet measure criterion.
Notes:
- Measure developers should address multiple administrations over a period of time using CQL logic.
- negation rationale indicates a one-time documentation of a reason an activity is not performed. Negation of QDM datatype-related actions for a reason always use the author dateTime attribute to reference timing and must not use relevantPeriod.
Refer to Special Cases in Appendix A (Section 5.7) for scenarios to consider in calculating cumulative medication duration.
["Medication, Order": "Injectable Factor Xa Inhibitor for VTE Prophylaxis"]
Value Set Description from VSAC
Clinical Focus: This value set contains concepts that represent codes which identify injectable factor Xa inhibitors, which are used for venous thromboembolism (VTE) prophylaxis.
Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Medication. The intent of this data element is to identify patients who are on a select injectable factor Xa inhibitor as prophylaxis for VTE.
Inclusion Criteria: Includes only relevant concepts associated with injectable factor Xa inhibitor medications. These are RxNorm codes.
Exclusion Criteria: No exclusions.
Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Medication. The intent of this data element is to identify patients who are on a select injectable factor Xa inhibitor as prophylaxis for VTE.
Inclusion Criteria: Includes only relevant concepts associated with injectable factor Xa inhibitor medications. These are RxNorm codes.
Exclusion Criteria: No exclusions.
Constrained to codes in the Medication, Order: Injectable Factor Xa Inhibitor for VTE Prophylaxis value set (2.16.840.1.113883.3.117.1.7.1.211)
QDM Datatype and Definition
"Medication, Order"
Data elements that meet criteria using this datatype should document a request to a pharmacy to provide the medication indicated by the QDM category and its corresponding value set.
Timing:
- relevantPeriod addresses the time referenced in the dosage instruction indicating when the medication administration should start and end.
- In the initial publication of QDM 5.5, relevantPeriod referenced the validity period, i.e., the time period for which the ordered supply is authorized by the prescription authorizing the dispensing event.
- For clarification, see Appendix 6.4 with additional guidance for referencing relevantPeriod updating the definition for Medication, Order, "Medication Dispensed", and "Substance, Order".
- author dateTime references the date and time the medication order (prescription) or the reason for not ordering the medication (i.e., negationRationale) is authored.
Notes:
- When calculating cumulative medication duration, the stopTime may be present directly in the medication order. If the stopTime is not available, the duration in days is the difference between the relevantPeriod start and stop times multiplied by (1 + the number of refills).
- negation rationale indicates a one-time documentation of a reason an activity is not performed. Negation of QDM datatype-related actions for a reason always use the author dateTime attribute to reference timing and must not use relevantPeriod.
Refer to Special Cases in Appendix A (Section 5.7) for scenarios to consider in calculating cumulative medication duration.
["Medication, Administered": "Low Dose Unfractionated Heparin for VTE Prophylaxis"]
Value Set Description from VSAC
Clinical Focus: This value set contains concepts that represent unfractionated heparin medications with strengths that could reasonably be used for venous thromboembolism (VTE) prophylaxis.
Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Medication. The intent of this data element is to identify patients who are on low-dose unfractionated heparin as VTE prophylaxis.
Inclusion Criteria: Includes only relevant concepts associated with injectable products that could reasonably be used to achieve a dose of at least 5000 units when administered subcutaneously.
Exclusion Criteria: Excludes concentrations less than 250 units/mL.
Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Medication. The intent of this data element is to identify patients who are on low-dose unfractionated heparin as VTE prophylaxis.
Inclusion Criteria: Includes only relevant concepts associated with injectable products that could reasonably be used to achieve a dose of at least 5000 units when administered subcutaneously.
Exclusion Criteria: Excludes concentrations less than 250 units/mL.
Constrained to codes in the Medication, Administered: Low Dose Unfractionated Heparin for VTE Prophylaxis value set (2.16.840.1.113762.1.4.1045.39)
QDM Datatype and Definition
"Medication, Administered"
Data elements that meet criteria using this datatype should document that the medication indicated by the QDM category and its corresponding value set was actually administered to the patient.
Timing:
- relevant dateTime references the time the medication is administered if it was given or taken at a single point in time.
- relevantPeriod references a start and stop time for medication administration if the administration event occurred over a time interval (e.g., an intravenous infusion). The relevantPeriod addresses:
- startTime - when a single medication administration event starts (e.g., the initiation of an intravenous infusion).
- stopTime - when a single medication administration event ends (e.g., the end time of the intravenous infusion).
- author dateTime references the time the action was recorded.
- Refer to the eCQM expression to determine allowable timings to meet measure criterion.
Notes:
- Measure developers should address multiple administrations over a period of time using CQL logic.
- negation rationale indicates a one-time documentation of a reason an activity is not performed. Negation of QDM datatype-related actions for a reason always use the author dateTime attribute to reference timing and must not use relevantPeriod.
Refer to Special Cases in Appendix A (Section 5.7) for scenarios to consider in calculating cumulative medication duration.
["Medication, Order": "Low Dose Unfractionated Heparin for VTE Prophylaxis"]
Value Set Description from VSAC
Clinical Focus: This value set contains concepts that represent unfractionated heparin medications with strengths that could reasonably be used for venous thromboembolism (VTE) prophylaxis.
Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Medication. The intent of this data element is to identify patients who are on low-dose unfractionated heparin as VTE prophylaxis.
Inclusion Criteria: Includes only relevant concepts associated with injectable products that could reasonably be used to achieve a dose of at least 5000 units when administered subcutaneously.
Exclusion Criteria: Excludes concentrations less than 250 units/mL.
Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Medication. The intent of this data element is to identify patients who are on low-dose unfractionated heparin as VTE prophylaxis.
Inclusion Criteria: Includes only relevant concepts associated with injectable products that could reasonably be used to achieve a dose of at least 5000 units when administered subcutaneously.
Exclusion Criteria: Excludes concentrations less than 250 units/mL.
Constrained to codes in the Medication, Order: Low Dose Unfractionated Heparin for VTE Prophylaxis value set (2.16.840.1.113762.1.4.1045.39)
QDM Datatype and Definition
"Medication, Order"
Data elements that meet criteria using this datatype should document a request to a pharmacy to provide the medication indicated by the QDM category and its corresponding value set.
Timing:
- relevantPeriod addresses the time referenced in the dosage instruction indicating when the medication administration should start and end.
- In the initial publication of QDM 5.5, relevantPeriod referenced the validity period, i.e., the time period for which the ordered supply is authorized by the prescription authorizing the dispensing event.
- For clarification, see Appendix 6.4 with additional guidance for referencing relevantPeriod updating the definition for Medication, Order, "Medication Dispensed", and "Substance, Order".
- author dateTime references the date and time the medication order (prescription) or the reason for not ordering the medication (i.e., negationRationale) is authored.
Notes:
- When calculating cumulative medication duration, the stopTime may be present directly in the medication order. If the stopTime is not available, the duration in days is the difference between the relevantPeriod start and stop times multiplied by (1 + the number of refills).
- negation rationale indicates a one-time documentation of a reason an activity is not performed. Negation of QDM datatype-related actions for a reason always use the author dateTime attribute to reference timing and must not use relevantPeriod.
Refer to Special Cases in Appendix A (Section 5.7) for scenarios to consider in calculating cumulative medication duration.
["Medication, Administered": "Low Molecular Weight Heparin for VTE Prophylaxis"]
Value Set Description from VSAC
Clinical Focus: This value set contains concepts that represent low molecular weight heparin medications used for Venous Thromboembolism (VTE) prophylaxis. The medications included in this value set are administered parenterally.
Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Medication. The intent of this data element is to identify patients who are on low molecular weight heparin therapy as VTE prophylaxis.
Inclusion Criteria: Includes only relevant concepts associated with RxNorm codes that specifically represent low molecular weight heparins that are administered parenterally.
Exclusion Criteria: No exclusions.
Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Medication. The intent of this data element is to identify patients who are on low molecular weight heparin therapy as VTE prophylaxis.
Inclusion Criteria: Includes only relevant concepts associated with RxNorm codes that specifically represent low molecular weight heparins that are administered parenterally.
Exclusion Criteria: No exclusions.
Constrained to codes in the Medication, Administered: Low Molecular Weight Heparin for VTE Prophylaxis value set (2.16.840.1.113883.3.117.1.7.1.219)
QDM Datatype and Definition
"Medication, Administered"
Data elements that meet criteria using this datatype should document that the medication indicated by the QDM category and its corresponding value set was actually administered to the patient.
Timing:
- relevant dateTime references the time the medication is administered if it was given or taken at a single point in time.
- relevantPeriod references a start and stop time for medication administration if the administration event occurred over a time interval (e.g., an intravenous infusion). The relevantPeriod addresses:
- startTime - when a single medication administration event starts (e.g., the initiation of an intravenous infusion).
- stopTime - when a single medication administration event ends (e.g., the end time of the intravenous infusion).
- author dateTime references the time the action was recorded.
- Refer to the eCQM expression to determine allowable timings to meet measure criterion.
Notes:
- Measure developers should address multiple administrations over a period of time using CQL logic.
- negation rationale indicates a one-time documentation of a reason an activity is not performed. Negation of QDM datatype-related actions for a reason always use the author dateTime attribute to reference timing and must not use relevantPeriod.
Refer to Special Cases in Appendix A (Section 5.7) for scenarios to consider in calculating cumulative medication duration.
["Medication, Order": "Low Molecular Weight Heparin for VTE Prophylaxis"]
Value Set Description from VSAC
Clinical Focus: This value set contains concepts that represent low molecular weight heparin medications used for Venous Thromboembolism (VTE) prophylaxis. The medications included in this value set are administered parenterally.
Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Medication. The intent of this data element is to identify patients who are on low molecular weight heparin therapy as VTE prophylaxis.
Inclusion Criteria: Includes only relevant concepts associated with RxNorm codes that specifically represent low molecular weight heparins that are administered parenterally.
Exclusion Criteria: No exclusions.
Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Medication. The intent of this data element is to identify patients who are on low molecular weight heparin therapy as VTE prophylaxis.
Inclusion Criteria: Includes only relevant concepts associated with RxNorm codes that specifically represent low molecular weight heparins that are administered parenterally.
Exclusion Criteria: No exclusions.
Constrained to codes in the Medication, Order: Low Molecular Weight Heparin for VTE Prophylaxis value set (2.16.840.1.113883.3.117.1.7.1.219)
QDM Datatype and Definition
"Medication, Order"
Data elements that meet criteria using this datatype should document a request to a pharmacy to provide the medication indicated by the QDM category and its corresponding value set.
Timing:
- relevantPeriod addresses the time referenced in the dosage instruction indicating when the medication administration should start and end.
- In the initial publication of QDM 5.5, relevantPeriod referenced the validity period, i.e., the time period for which the ordered supply is authorized by the prescription authorizing the dispensing event.
- For clarification, see Appendix 6.4 with additional guidance for referencing relevantPeriod updating the definition for Medication, Order, "Medication Dispensed", and "Substance, Order".
- author dateTime references the date and time the medication order (prescription) or the reason for not ordering the medication (i.e., negationRationale) is authored.
Notes:
- When calculating cumulative medication duration, the stopTime may be present directly in the medication order. If the stopTime is not available, the duration in days is the difference between the relevantPeriod start and stop times multiplied by (1 + the number of refills).
- negation rationale indicates a one-time documentation of a reason an activity is not performed. Negation of QDM datatype-related actions for a reason always use the author dateTime attribute to reference timing and must not use relevantPeriod.
Refer to Special Cases in Appendix A (Section 5.7) for scenarios to consider in calculating cumulative medication duration.
["Medication, Administered": "Rivaroxaban and Betrixaban for VTE Prophylaxis"]
Value Set Description from VSAC
Clinical Focus: This value set contains concepts that represent Rivaroxaban and Betrixaban indicated for venous thromboembolism (VTE) prophylaxis and treatment.
Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Medication. The intent of this data element is to identify patients who receive Rivaroxaban and Betrixaban for VTE prophylaxis.
Inclusion Criteria: Includes only relevant concepts associated with oral forms of Rivaroxaban and Betrixaban.
Exclusion Criteria: NA
Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Medication. The intent of this data element is to identify patients who receive Rivaroxaban and Betrixaban for VTE prophylaxis.
Inclusion Criteria: Includes only relevant concepts associated with oral forms of Rivaroxaban and Betrixaban.
Exclusion Criteria: NA
Constrained to codes in the Medication, Administered: Rivaroxaban and Betrixaban for VTE Prophylaxis value set (2.16.840.1.113762.1.4.1110.50)
QDM Datatype and Definition
"Medication, Administered"
Data elements that meet criteria using this datatype should document that the medication indicated by the QDM category and its corresponding value set was actually administered to the patient.
Timing:
- relevant dateTime references the time the medication is administered if it was given or taken at a single point in time.
- relevantPeriod references a start and stop time for medication administration if the administration event occurred over a time interval (e.g., an intravenous infusion). The relevantPeriod addresses:
- startTime - when a single medication administration event starts (e.g., the initiation of an intravenous infusion).
- stopTime - when a single medication administration event ends (e.g., the end time of the intravenous infusion).
- author dateTime references the time the action was recorded.
- Refer to the eCQM expression to determine allowable timings to meet measure criterion.
Notes:
- Measure developers should address multiple administrations over a period of time using CQL logic.
- negation rationale indicates a one-time documentation of a reason an activity is not performed. Negation of QDM datatype-related actions for a reason always use the author dateTime attribute to reference timing and must not use relevantPeriod.
Refer to Special Cases in Appendix A (Section 5.7) for scenarios to consider in calculating cumulative medication duration.
["Medication, Order": "Rivaroxaban and Betrixaban for VTE Prophylaxis"]
Value Set Description from VSAC
Clinical Focus: This value set contains concepts that represent Rivaroxaban and Betrixaban indicated for venous thromboembolism (VTE) prophylaxis and treatment.
Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Medication. The intent of this data element is to identify patients who receive Rivaroxaban and Betrixaban for VTE prophylaxis.
Inclusion Criteria: Includes only relevant concepts associated with oral forms of Rivaroxaban and Betrixaban.
Exclusion Criteria: NA
Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Medication. The intent of this data element is to identify patients who receive Rivaroxaban and Betrixaban for VTE prophylaxis.
Inclusion Criteria: Includes only relevant concepts associated with oral forms of Rivaroxaban and Betrixaban.
Exclusion Criteria: NA
Constrained to codes in the Medication, Order: Rivaroxaban and Betrixaban for VTE Prophylaxis value set (2.16.840.1.113762.1.4.1110.50)
QDM Datatype and Definition
"Medication, Order"
Data elements that meet criteria using this datatype should document a request to a pharmacy to provide the medication indicated by the QDM category and its corresponding value set.
Timing:
- relevantPeriod addresses the time referenced in the dosage instruction indicating when the medication administration should start and end.
- In the initial publication of QDM 5.5, relevantPeriod referenced the validity period, i.e., the time period for which the ordered supply is authorized by the prescription authorizing the dispensing event.
- For clarification, see Appendix 6.4 with additional guidance for referencing relevantPeriod updating the definition for Medication, Order, "Medication Dispensed", and "Substance, Order".
- author dateTime references the date and time the medication order (prescription) or the reason for not ordering the medication (i.e., negationRationale) is authored.
Notes:
- When calculating cumulative medication duration, the stopTime may be present directly in the medication order. If the stopTime is not available, the duration in days is the difference between the relevantPeriod start and stop times multiplied by (1 + the number of refills).
- negation rationale indicates a one-time documentation of a reason an activity is not performed. Negation of QDM datatype-related actions for a reason always use the author dateTime attribute to reference timing and must not use relevantPeriod.
Refer to Special Cases in Appendix A (Section 5.7) for scenarios to consider in calculating cumulative medication duration.
["Medication, Administered": "Warfarin"]
Value Set Description from VSAC
Clinical Focus: This value set contains concepts that represent warfarin medications that are administered to patients to reduce the risk of blood clot formation.
Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Medication. The intent of this data element is to identify patients who are prescribed warfarin therapy at discharge following acute myocardial infarction.
Inclusion Criteria: Includes only relevant concepts associated with drug forms that are consistent with oral administration, such as tablets. Only single ingredient.
Exclusion Criteria: No exclusions.
Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Medication. The intent of this data element is to identify patients who are prescribed warfarin therapy at discharge following acute myocardial infarction.
Inclusion Criteria: Includes only relevant concepts associated with drug forms that are consistent with oral administration, such as tablets. Only single ingredient.
Exclusion Criteria: No exclusions.
Constrained to codes in the Medication, Administered: Warfarin value set (2.16.840.1.113883.3.117.1.7.1.232)
QDM Datatype and Definition
"Medication, Administered"
Data elements that meet criteria using this datatype should document that the medication indicated by the QDM category and its corresponding value set was actually administered to the patient.
Timing:
- relevant dateTime references the time the medication is administered if it was given or taken at a single point in time.
- relevantPeriod references a start and stop time for medication administration if the administration event occurred over a time interval (e.g., an intravenous infusion). The relevantPeriod addresses:
- startTime - when a single medication administration event starts (e.g., the initiation of an intravenous infusion).
- stopTime - when a single medication administration event ends (e.g., the end time of the intravenous infusion).
- author dateTime references the time the action was recorded.
- Refer to the eCQM expression to determine allowable timings to meet measure criterion.
Notes:
- Measure developers should address multiple administrations over a period of time using CQL logic.
- negation rationale indicates a one-time documentation of a reason an activity is not performed. Negation of QDM datatype-related actions for a reason always use the author dateTime attribute to reference timing and must not use relevantPeriod.
Refer to Special Cases in Appendix A (Section 5.7) for scenarios to consider in calculating cumulative medication duration.
["Medication, Order": "Warfarin"]
Value Set Description from VSAC
Clinical Focus: This value set contains concepts that represent warfarin medications that are administered to patients to reduce the risk of blood clot formation.
Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Medication. The intent of this data element is to identify patients who are prescribed warfarin therapy at discharge following acute myocardial infarction.
Inclusion Criteria: Includes only relevant concepts associated with drug forms that are consistent with oral administration, such as tablets. Only single ingredient.
Exclusion Criteria: No exclusions.
Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Medication. The intent of this data element is to identify patients who are prescribed warfarin therapy at discharge following acute myocardial infarction.
Inclusion Criteria: Includes only relevant concepts associated with drug forms that are consistent with oral administration, such as tablets. Only single ingredient.
Exclusion Criteria: No exclusions.
Constrained to codes in the Medication, Order: Warfarin value set (2.16.840.1.113883.3.117.1.7.1.232)
QDM Datatype and Definition
"Medication, Order"
Data elements that meet criteria using this datatype should document a request to a pharmacy to provide the medication indicated by the QDM category and its corresponding value set.
Timing:
- relevantPeriod addresses the time referenced in the dosage instruction indicating when the medication administration should start and end.
- In the initial publication of QDM 5.5, relevantPeriod referenced the validity period, i.e., the time period for which the ordered supply is authorized by the prescription authorizing the dispensing event.
- For clarification, see Appendix 6.4 with additional guidance for referencing relevantPeriod updating the definition for Medication, Order, "Medication Dispensed", and "Substance, Order".
- author dateTime references the date and time the medication order (prescription) or the reason for not ordering the medication (i.e., negationRationale) is authored.
Notes:
- When calculating cumulative medication duration, the stopTime may be present directly in the medication order. If the stopTime is not available, the duration in days is the difference between the relevantPeriod start and stop times multiplied by (1 + the number of refills).
- negation rationale indicates a one-time documentation of a reason an activity is not performed. Negation of QDM datatype-related actions for a reason always use the author dateTime attribute to reference timing and must not use relevantPeriod.
Refer to Special Cases in Appendix A (Section 5.7) for scenarios to consider in calculating cumulative medication duration.
Last Updated: Jun 08, 2020